StonvexLoading…
StonvexStonvexStonvexCore line items from CACI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $6.86B | $4.51B | $2.29B | $8.63B |
Operating Income | $647.62M | $418.74M | $212.28M | $764.18M |
Net Income | $379.06M | $248.66M | $124.81M | $499.83M |
EPS (Diluted) | $17.11 | $11.22 | $5.63 | $22.32 |
Total Assets | $11.60B | $8.93B | $8.70B | $8.65B |
Total Liabilities | $7.32B | $4.80B | $4.68B | $4.75B |
Cash & Equivalents | $158.00M | $422.98M | $133.02M | $106.18M |
Free Cash Flow OCF − CapEx | $448.57M | $292.20M | $154.05M | $481.41M |
Shares Outstanding | 22.09M | 22.08M | 21.99M | 21.99M |